Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 587.25M P/E - EPS this Y 13.60% Ern Qtrly Grth -
Income -44.05M Forward P/E -4.76 EPS next Y -41.20% 50D Avg Chg 1.00%
Sales 15.13M PEG -0.28 EPS past 5Y - 200D Avg Chg -13.00%
Dividend N/A Price/Book 1.72 EPS next 5Y 145.30% 52W High Chg -46.00%
Recommedations 1.60 Quick Ratio 57.03 Shares Outstanding 52.16M 52W Low Chg 28.00%
Insider Own 9.27% ROA -7.98% Shares Float 32.13M Beta 3.57
Inst Own 98.39% ROE -9.20% Shares Shorted/Prior 3.31M/3.25M Price 12.77
Gross Margin -251.04% Profit Margin -291.17% Avg. Volume 152,358 Target Price 67.50
Oper. Margin -155.36% Earnings Date Aug 7 Volume 62,386 Change -3.55%
About Janux Therapeutics, Inc.

Janux Therapeutics, Inc., a clinical stage biopharmaceutical company, develops immunotherapies based on Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr) platforms technology to treat patients suffering from cancer. The company's clinical candidates comprise JANX007, a prostate-specific membrane antigen or PSMA-TRACTr, which is in Phase 1 clinical trial in adults for the treatment of metastatic castration-resistant prostate cancer (mCRPC) and the vasculature of other tumors; and JANX008, an epidermal growth factor receptor or EGFR-TRACTr that is in Phase 1 clinical trial for the treatment of multiple solid cancers, including colorectal cancer, squamous cell carcinoma of the head and neck, non-small cell lung cancer, and renal cell carcinoma. Its development pipeline also consists of discovery stage products. The company has strategic research collaboration agreement with Merck Sharp & Dohme Corp. to develop TRACTr product candidates. Janux Therapeutics, Inc. was incorporated in 2017 and is headquartered in San Diego, California.

Janux Therapeutics, Inc. News
11/15/24 Bitdeer Technologies, PBF Energy, and More Stocks See Action From Activist Investors
11/08/24 Janux Therapeutics Third Quarter 2024 Earnings: Misses Expectations
11/06/24 Janux Therapeutics Reports Third Quarter 2024 Financial Results and Business Highlights
11/01/24 Bath & Body Works, Paramount Global, and More Stocks See Action From Activist Investors
10/16/24 Janux Therapeutics (NASDAQ:JANX) Is In A Strong Position To Grow Its Business
10/07/24 Janux Therapeutics, Inc. (JANX): A Hot Stock to Buy Now
09/26/24 Is Janux Therapeutics Inc. (JANX) the Best Performing Small-Cap Stock in 2024?
09/20/24 Lennar, Bitdeer, and More Stocks See Action From Activist Investors
09/17/24 RA Capital Management L.P. Increases Stake in Janux Therapeutics Inc
09/14/24 Janux Therapeutics, Inc. (JANX): Among Hedge Funds’ Top Biotech Stock Picks
09/13/24 Janux Therapeutics (JANX) Moves 6.5% Higher: Will This Strength Last?
08/07/24 Janux Therapeutics, Inc. (JANX) Reports Q2 Loss, Tops Revenue Estimates
08/07/24 Janux Therapeutics Reports Second Quarter 2024 Financial Results and Business Highlights
07/22/24 Janux Therapeutics Announces Updates to Board of Directors
05/09/24 We're Not Very Worried About Janux Therapeutics' (NASDAQ:JANX) Cash Burn Rate
05/08/24 Janux Therapeutics Reports Narrower Q1 Loss, Misses Revenue Estimates
05/07/24 Janux Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights
04/30/24 Here's What Could Help Janux Therapeutics (JANX) Maintain Its Recent Price Strength
04/17/24 Take the Money and Run: 3 Overbought Stocks to Sell ASAP
04/16/24 These 3 Biotech Stocks Are Up 269% in 2024. Is There More to Come?
JANX Chatroom

User Image bigkahunatrader Posted - 2 days ago

$JANX Janx Therapeutics, Inc....CAT-3 in PBC Zone...this one will turn fast-so keep an eye on it... https://youtu.be/SIyQyAX6j0A

User Image hashinvests200 Posted - 3 days ago

A Glimpse into My 2025 Stock Picks (US Edition) As we enter 2025, the U.S. stock market presents a landscape ripe with opportunities. The Federal Reserve's recent meeting minutes indicate a cautious yet optimistic approach, suggesting that while inflationary pressures are being monitored, the overall economic outlook remains positive. This balanced stance bodes well for investors seeking growth in the coming year... Full here: https://medium.com/@wng240/a-glimpse-into-my-2025-stock-picks-us-edition-e48d0da3e63f $JANX $RYDE

User Image JoshThe3rd Posted - 1 week ago

$JANX looking for another MA50 Daily add.

User Image flytrader1 Posted - 1 week ago

$JANX any reason for the dip today? Don't see any news

User Image NVDAMillionaire Posted - 1 week ago

$JANX Janux Therapeutics (NASDAQ:JANX): Pioneering Innovative Cancer Therapies https://beyondspx.com/article/janux-therapeutics-nasdaq-janx-pioneering-innovative-cancer-therapies

User Image Quantumup Posted - 1 week ago

BofA⬆️PT $JANX $65 was $59/Buy+⬆️PoS '007 (44% to 50%)/'008 (34% to 38%), after 3Q24💰wrap-up. BofA⬆️PT on compelling TRACTr programs w/ potential best-in-class (BiC) profiles ahead of major de-risking🔬in the near term: $nvo $amgn $jnj $rgen Also Mentioned in BofA's 3Q24 Earnings Wrap-up: alec xncr ymab rgnx rxrx ntla crbu sana

User Image Thelonius_Stonk Posted - 2 weeks ago

$JANX potential monster move coming out of this consolidation

User Image insiderbuyingselling Posted - 10/31/24

$JANX new insider selling: 25000 shares. http://insiderbuyingselling.com/?t=JANX

User Image Quantumup Posted - 10/27/24

BofA $IMTX, $NTLA, $JANX, $KRYS, $NVAX

User Image FlynancialAnalyst Posted - 10/26/24

$JANX this one is $VERA special! Just keeps swimming in spite of $XBI chop, 3rd accumulation wk in a row DD ^^ unchanged

User Image justiceforb_85 Posted - 10/25/24

$JANX is there any other company working on a PSMA and CD3 bispecific antibody? JNJ previously worked on one (JNJ-081) but nothing reported recently on it...

User Image insiderbuyingselling Posted - 10/24/24

$JANX new insider selling: 3815 shares. http://insiderbuyingselling.com/?t=JANX

User Image stockpicker63 Posted - 10/24/24

Watch today $JANX, $LRCX and $CLS

User Image Quantumup Posted - 10/24/24

UBS🏁 $JANX Buy/$69—believes $JANX's lead, JANX007, c/b a transformative Tx in PCa—est $2.1B peak sales pot vs $1.5B cons, based on competitive efficacy/clean safety profile in early Ph1 trial—believes several near-term value-inflecting🐈s could validate platform/programs2🚘⬆️side:

User Image OpenOutcrier Posted - 10/23/24

$JANX (+3.6% pre) Form 4 Janux Therapeutics, Inc. For: Oct 18 Filed by: Shah Rajeev M. https://ooc.bz/l/45522

User Image QuiverQuant Posted - 10/22/24

🚨 Massive New Insider Purchase Ra Capital Management, who has a board seat at $JANX, just reported the purchase of $53m of the company's stock. $JANX currently has an ongoing Phase 1 trial evaluating JANX007 as a potential treatment for prostate cancer. You can track Quiver's Insider Purchases strategy at quiverquant.com/strategies/

User Image insiderbuyingselling Posted - 10/22/24

$JANX new insider buying: 1200000 shares. http://insiderbuyingselling.com/?t=JANX

User Image seet79 Posted - 10/22/24

$JANX do we get data in November or December?

User Image insiderbuyingselling Posted - 1 month ago

$JANX new insider selling: 1673128 shares. http://insiderbuyingselling.com/?t=JANX

User Image biochirp Posted - 1 month ago

$LVTX will have a $DRUG like day after $JANX is bought

User Image net0trader Posted - 1 month ago

$JANX having a good few days, but it may not be done yet. Chart looking explosive. @MaverikIT @IsabellaDC

User Image FlynancialAnalyst Posted - 1 month ago

$XBI $JANX

User Image yus37 Posted - 1 month ago

$CTMX ......... Keeping an eye on it ...it's extremely undervalued IMO. The big pharma partnerships should be worth more than a dollar per share... Plus, the pipeline looks promising despite the last data fiasco that turned into one of the wildest rollercoaster rides this year....Lol... $XBI $JANX

User Image Thinklikethecompany Posted - 1 month ago

$JANX shhhhh, let's remain quiet and patient. Thus far, deferred gratification has paid off handsomely for us:-))) https://www.youtube.com/watch?v=2-UQ0-8ktAM

User Image flytrader1 Posted - 1 month ago

$JANX they should be sharing new data soon

User Image KaGi77 Posted - 1 month ago

@LabPsycho Or they could be like $JANX insiders and sell of shares all year and still see the SP increase. Makes no sense.

User Image FlynancialAnalyst Posted - 1 month ago

Don't get it $TWST 'd, $JANX is looking $VERA special $XBI

User Image FlynancialAnalyst Posted - 1 month ago

$JANX $2.47B mc $XBI #ShortSqueeze name continues to impress, accumulation wk off 10 wk SMA just above key $40 level FOUNDER LED, 9.27% insider owned Pct of all funds long share at record highs & rising TrendEdge.app/asset/JANX

User Image StockConsultant Posted - 1 month ago

$JANX Janux Therapeutics stock nice move the 44.84 triple support area at https://stockconsultant.com/?JANX

User Image seet79 Posted - 1 month ago

@Kingjake26 this is a retail stock. Too many many people in with no clue. $JANX is the perfect stock basically- no engagement- nobody pays attention to the company and it keeps going higher-

Analyst Ratings
Cantor Fitzgerald Overweight Sep 16, 24
Stifel Buy Sep 6, 24
HC Wainwright & Co. Buy Aug 19, 24
Scotiabank Sector Perform Aug 9, 24
Cantor Fitzgerald Overweight Aug 8, 24
Wedbush Outperform Aug 8, 24
Scotiabank Sector Perform May 30, 24
HC Wainwright & Co. Buy May 13, 24
Cantor Fitzgerald Overweight May 9, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Reardon Tighe Acting Chief Financi.. Acting Chief Financial Officer Nov 13 Buy 5.87 849,854 4,988,643 849,854 11/15/23
Lichter Jay Director Director Nov 13 Buy 5.87 849,854 4,988,643 849,854 11/15/23
Avalon Ventures XI, L.P. 10% Owner 10% Owner Nov 13 Buy 5.87 849,854 4,988,643 849,854 11/13/23
ORBIMED ADVISORS LLC Director Director Dec 29 Sell 20.3 40,400 820,120 231,098 12/30/21
Thompson Peter A. Director Director Dec 29 Sell 20.3 40,400 820,120 231,098 12/30/21